JP2023540526A5 - - Google Patents

Info

Publication number
JP2023540526A5
JP2023540526A5 JP2023514862A JP2023514862A JP2023540526A5 JP 2023540526 A5 JP2023540526 A5 JP 2023540526A5 JP 2023514862 A JP2023514862 A JP 2023514862A JP 2023514862 A JP2023514862 A JP 2023514862A JP 2023540526 A5 JP2023540526 A5 JP 2023540526A5
Authority
JP
Japan
Prior art keywords
seq
sequence
nectin
cdr1
cdr2
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023514862A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023540526A (ja
JP7851914B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/049014 external-priority patent/WO2022051591A2/en
Publication of JP2023540526A publication Critical patent/JP2023540526A/ja
Publication of JP2023540526A5 publication Critical patent/JP2023540526A5/ja
Application granted granted Critical
Publication of JP7851914B2 publication Critical patent/JP7851914B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023514862A 2020-09-04 2021-09-03 ネクチン-4抗体およびそれの使用 Active JP7851914B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063074864P 2020-09-04 2020-09-04
US63/074,864 2020-09-04
US202163166622P 2021-03-26 2021-03-26
US63/166,622 2021-03-26
PCT/US2021/049014 WO2022051591A2 (en) 2020-09-04 2021-09-03 Nectin-4 antibodies and uses thereof

Publications (3)

Publication Number Publication Date
JP2023540526A JP2023540526A (ja) 2023-09-25
JP2023540526A5 true JP2023540526A5 (https=) 2024-09-09
JP7851914B2 JP7851914B2 (ja) 2026-04-27

Family

ID=78080439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023514862A Active JP7851914B2 (ja) 2020-09-04 2021-09-03 ネクチン-4抗体およびそれの使用

Country Status (7)

Country Link
US (1) US20230331867A1 (https=)
EP (1) EP4208259A2 (https=)
JP (1) JP7851914B2 (https=)
KR (1) KR20230060509A (https=)
AU (1) AU2021337687A1 (https=)
CA (1) CA3193584A1 (https=)
WO (1) WO2022051591A2 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4096717B1 (en) 2020-01-31 2024-12-11 Innate Pharma Treatment of cancer
US20230181749A1 (en) * 2020-05-20 2023-06-15 Bicycle TX Limited Bicyclic peptide ligands specific for nectin-4 and uses thereof
US20240366778A1 (en) * 2021-08-27 2024-11-07 Cspc Megalith Biopharmarceutical Co., Ltd. Anti-nectin-4 antibody, drug conjugate, and preparation method therefor and use thereof
CN116063498A (zh) * 2022-04-27 2023-05-05 博际生物医药科技(杭州)有限公司 单域抗Nectin-4抗体
JP2025517476A (ja) * 2022-05-25 2025-06-05 イナート・ファルマ・ソシエテ・アノニム ネクチン-4結合剤
CA3262070A1 (en) * 2022-07-14 2025-06-13 Bio-Thera Solutions, Ltd. ANTI-NECTIN-4 ANTIBODIES AND THEIR USES
CN120239708A (zh) * 2022-09-20 2025-07-01 耐科廷疗法有限公司 针对黏连蛋白4的人源化抗体及其药物偶联物
JP7689606B2 (ja) * 2023-06-20 2025-06-06 イーライ リリー アンド カンパニー ネクチン-4抗体及び抗体-薬物コンジュゲート
KR20250177512A (ko) * 2024-06-14 2025-12-24 삼성바이오에피스 주식회사 신규한 항-넥틴-4 항체 및 이의 용도

Family Cites Families (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154598B (nl) 1970-11-10 1977-09-15 Organon Nv Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking.
US3817837A (en) 1971-05-14 1974-06-18 Syva Corp Enzyme amplification assay
US4277437A (en) 1978-04-05 1981-07-07 Syva Company Kit for carrying out chemically induced fluorescence immunoassay
US4275149A (en) 1978-11-24 1981-06-23 Syva Company Macromolecular environment control in specific receptor assays
US4366241A (en) 1980-08-07 1982-12-28 Syva Company Concentrating zone method in heterogeneous immunoassays
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4737456A (en) 1985-05-09 1988-04-12 Syntex (U.S.A.) Inc. Reducing interference in ligand-receptor binding assays
US6548640B1 (en) 1986-03-27 2003-04-15 Btg International Limited Altered antibodies
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
FR2646437B1 (fr) 1989-04-28 1991-08-30 Transgene Sa Nouvelles sequences d'adn, leur application en tant que sequence codant pour un peptide signal pour la secretion de proteines matures par des levures recombinantes, cassettes d'expression, levures transformees et procede de preparation de proteines correspondant
US6075181A (en) 1990-01-12 2000-06-13 Abgenix, Inc. Human antibodies derived from immunized xenomice
US6150584A (en) 1990-01-12 2000-11-21 Abgenix, Inc. Human antibodies derived from immunized xenomice
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
ATE158021T1 (de) 1990-08-29 1997-09-15 Genpharm Int Produktion und nützung nicht-menschliche transgentiere zur produktion heterologe antikörper
WO1992022645A1 (en) 1991-06-14 1992-12-23 Genpharm International, Inc. Transgenic immunodeficient non-human animals
EP1400536A1 (en) 1991-06-14 2004-03-24 Genentech Inc. Method for making humanized antibodies
CA2113113A1 (en) 1991-07-08 1993-01-21 Simon W. Kantor Thermotropic liquid crystal segmented block copolymer
JPH08509612A (ja) 1993-04-26 1996-10-15 ジェンファーム インターナショナル インコーポレイテッド 異種抗体を産生することができるトランスジェニック非ヒト動物
DK1034298T3 (da) 1997-12-05 2012-01-30 Scripps Research Inst Humanisering af murint antistof
MXPA02000962A (es) 1999-07-29 2002-07-02 Medarex Inc Anticuerpos monoclonales humanos para her2/neu.
US7271240B2 (en) 2001-03-14 2007-09-18 Agensys, Inc. 125P5C8: a tissue specific protein highly expressed in various cancers
AU2003243151A1 (en) 2002-08-16 2004-03-03 Agensys, Inc. Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
EP1740615B1 (en) 2004-03-31 2014-11-05 Genentech, Inc. Humanized anti-tgf-beta antibodies
CL2008001334A1 (es) 2007-05-08 2008-09-22 Genentech Inc Anticuerpo anti-muc16 disenado con cisteina; conjugado que lo comprende; metodo de produccion; formulacion farmaceutica que lo comprende; y su uso para tratar el cancer.
NZ584514A (en) 2007-10-19 2012-07-27 Genentech Inc Cysteine engineered anti-tenb2 antibodies and antibody drug conjugates
CA2799540A1 (en) 2010-06-08 2011-12-15 Genentech, Inc. Cysteine engineered antibodies and conjugates
MX347954B (es) 2010-09-29 2017-05-19 Agensys Inc Conjugados de anticuerpo farmaco (adc) que enlazan a proteinas 191p4d12.
CN102469482A (zh) 2010-11-12 2012-05-23 中兴通讯股份有限公司 一种广播控制信道信息倒换方法及系统
EP2729898A1 (en) 2011-07-10 2014-05-14 Blendology Limited An electronic data sharing device and method of use
US20140283153A1 (en) 2011-10-28 2014-09-18 Trianni, Inc. Transgenic animals and methods of use
EP2793947B1 (en) 2011-12-23 2021-02-03 Innate Pharma Enzymatic conjugation of polypeptides
CN104640572B (zh) 2012-05-15 2018-04-27 索伦托医疗有限公司 药物偶联物,偶联方法,及其用途
EP2859017B1 (en) 2012-06-08 2019-02-20 Sutro Biopharma, Inc. Antibodies comprising site-specific non-natural amino acid residues, methods of their preparation and methods of their use
NO2789793T3 (https=) 2012-10-24 2018-01-27
EP3564259A3 (en) 2012-11-09 2020-02-12 Innate Pharma Recognition tags for tgase-mediated conjugation
EP3010547B1 (en) 2013-06-20 2021-04-21 Innate Pharma Enzymatic conjugation of polypeptides
CN105517577A (zh) 2013-06-21 2016-04-20 先天制药公司 多肽的酶促偶联
EP2845550B1 (de) 2013-09-10 2017-03-29 Erbe Elektromedizin GmbH Chirurgisches Instrument mit Kunststoffschaft
WO2015191883A1 (en) 2014-06-12 2015-12-17 Dophen Biomedical Homogenous antibody drug conjugates via enzymatic methods
PL3185908T3 (pl) 2014-08-28 2020-09-07 Pfizer Inc. Łączniki modulujące stabilność do stosowania z koniugatami przeciwciało-lek
JP6817288B2 (ja) 2015-08-10 2021-01-20 ハンジョウ ディーエーシー バイオテック シーオー.,エルティディ.Hangzhou Dac Biotech Co.,Ltd. 新規な連結体及び生体分子と薬物との特異的共役におけるその使用
JP2018525007A (ja) 2015-08-24 2018-09-06 トリアンニ インコーポレイテッドTrianni,Inc. 免疫グロブリンの産生増強
EP3347048B1 (en) 2015-09-09 2020-04-01 INSERM (Institut National de la Santé et de la Recherche Médicale) Antibodies having specificity to nectin-4 and uses thereof
JP2018531935A (ja) 2015-10-02 2018-11-01 ブリストル−マイヤーズ スクイブ カンパニーBristol−Myers Squibb Company 抗体を結合させるためのトランスグルタミナーゼバリアント
BR112018074453A2 (pt) 2016-05-27 2019-03-19 Abbvie Biotherapeutics Inc. proteínas de ligação biespecíficas ligando uma protéina imunomoduladora e um antígeno tumoral
US11014961B2 (en) 2017-01-25 2021-05-25 Massachusetts Institute Of Technology Self-labeling miniproteins and conjugates comprising them
CN110392697A (zh) 2017-03-02 2019-10-29 国家医疗保健研究所 对nectin-4具有特异性的抗体及其用途
KR20210122319A (ko) 2017-04-06 2021-10-08 항저우 디에이씨 바이오테크 씨오, 엘티디 비스-링키지를 사용한 세포독성 약물의 접합
WO2018226578A1 (en) * 2017-06-05 2018-12-13 Agensys, Inc. Nectin-4-binding proteins and methods of use thereof
JP6633247B1 (ja) 2018-05-07 2020-01-22 和寛 檜山 診断情報提供装置、方法及びシステム
KR102892725B1 (ko) 2018-05-09 2025-12-01 이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. 인간 넥틴4에 특이적인 항체

Similar Documents

Publication Publication Date Title
JP2023540526A5 (https=)
JP2022512132A5 (https=)
TWI777056B (zh) 結合至ssea4的單株抗體及其用途
JP2021534762A5 (https=)
JP2023509448A5 (https=)
JP2024522360A5 (https=)
JP2013502913A5 (https=)
JP2020525032A5 (https=)
JP2017535257A5 (https=)
JP2019513018A5 (https=)
JP2022533538A5 (https=)
JP2024531409A5 (https=)
CN112513094A (zh) 结合人her2的抗体、其制备方法和用途
JP2024001073A5 (https=)
JP2021530244A5 (https=)
JP2020522488A5 (https=)
JP2023543493A5 (https=)
JP2023518153A5 (https=)
JP2023509373A5 (https=)
JP2024016024A5 (https=)
JP2023516724A5 (https=)
JP2024540148A5 (https=)
CN108084265A (zh) 特异性结合人的5t4抗原的全人源单域抗体及其应用
JP2024515560A5 (https=)
CN115461373A (zh) 密蛋白18.2的抗体及其用途